May the robotic approach expand the indications for redo surgery in recurrent pNETs in Multiple Neuroendocrine Neoplasia type 1?

Pancreatic neuroendocrine tumors (pNETs) represent the leading cause of disease-specific mortality in patients with Multiple Neuroendocrine Neoplasia type 1 (MEN1). Although surgery is the recommended treatment for non-functional pNETs >2 cm, the management of recurrent lesions between 1 and 2 cm...

Descripción completa

Detalles Bibliográficos
Autores principales: Baz, Carolina, Dreifuss, Nicolas H, Cubisino, Antonio, Schlottmann, Francisco, Mangano, Alberto, Aguiluz, Gabriela, Vanetta, Carolina, Masrur, Mario A, Giulianotti, Pier Cristoforo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491866/
https://www.ncbi.nlm.nih.gov/pubmed/36158249
http://dx.doi.org/10.1093/jscr/rjac433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491866/
https://www.ncbi.nlm.nih.gov/pubmed/36158249
http://dx.doi.org/10.1093/jscr/rjac433

Ejemplares similares